Glial fibrillary acidic protein as a biomarker for visuospatial ability in Down syndrome

Abstract

Background: Down syndrome (DS) may serve as a model to understand biological factors modifying aging and cognitive decline, given the high incidence of Alzheimer's disease (AD) in individuals with DS.

The paper